MedPath
HSA Approval

DESLORATADINE SANDOZ FILM COATED TABLET 5MG

SIN15773P

DESLORATADINE SANDOZ FILM COATED TABLET 5MG

DESLORATADINE SANDOZ FILM COATED TABLET 5MG

August 7, 2019

NOVARTIS (SINGAPORE) PTE LTD

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R06AX27

desloratadine

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

Sandoz Private Limited

Active Ingredients

Desloratadine

5mg

Desloratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DESLORATADINE SANDOZ FILM COATED TABLET 5MG - HSA Approval | MedPath